Avelox Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study
Conditions:   Bacterial Keratitis;   Fungal Keratitis;   Mixed Bacterial and Fungal Keratitis;   Microbial Keratitis Interventions:   Drug: Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution;   Drug: Ceftazidime 5% + vancomycin 5%;   Drug: Gentamicin 1.4% + vancomycin 5%;   Drug: Natamycin 5% Oph Susp;   Drug: Voriconazole 1%;   Drug: Natamycin 5% + voriconazole 1%;   Drug: Natamycin 5%+ ceftazidime 5% + vancomycin 5%;   Drug: Voriconazole 1% + ceftazidime 5% + vancomycin 5% Sponsor:   Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials

A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants
Condition:   Healthy Interventions:   Drug: Selpercatinib;   Drug: Moxifloxacin;   Drug: Placebo Sponsors:   Eli Lilly and Company;   Loxo Oncology, Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2022 Category: Research Source Type: clinical trials